Screener
Revenue
Breakdown
Segments
Sterilization And Disinfection ControlView metric
Biopharmaceutical DevelopmentView metric
Clinical GenomicsView metric
Calibration SolutionsView metric
| Segment | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|
| Sterilization And Disinfection Control | $22.21M | $23.51M | $24.75M | $25.41M | $22.11M | $24.91M | $29.14M | $24.51M |
| Calibration Solutions | $12.26M | $14.43M | — | $12.35M | $13.57M | $14.07M | — | $13.29M |
| Biopharmaceutical Development | $11.87M | $12.24M | $12.62M | $11.49M | $13.92M | $14.37M | $8.85M | $12.06M |
| Clinical Genomics | $11.5M | $12.67M | $11.51M | $10.3M | $11.14M | $11.77M | $12.18M | $10.29M |
| Total | $57.83M | $62.84M | $62.14M | $59.54M | $60.74M | $65.13M | $63.72M | $60.14M |